Exploring prescription drug coverage and drug use for older Americans

Annals of Pharmacotherapy

Volumn 36, Issue 11, 2002, Pages 1704-1711

  Mott, David A ^a   Schommer, Jon C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Elderly; Insurance; Medicare

Indexed keywords

GENERIC DRUG;

AGED; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DRUG COST; DRUG USE; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE PAYMENT;

EID: 0036840853     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A329     Document Type: Article

References (23)

1. Washington B. Testimony on Prescription Drug Coverage for Medicare Beneficiaries before the House Commerce Health and Environment Subcommittee, Washington, DC. February 16, 2000 [cited 2001 March 19]. Available from: URL: www.hcfa.gov/testimony/2000/000216.htm.
2. Statistical Abstract of the United States: 1998. Washington, DC: US Bureau of the Census, 1998.
3. Adamcik BM. The consumers of health care. In: Fincham JE, Wertheimer AI, eds. Pharmacy and the US health Care System. 2nd Ed. Binghampton, NY: Pharmaceutical Products Press, 1998:337-94.
4. Sullivan SD, Gardner LB, Strandberg LT. The economics of outpatient prescription drug coverage for the elderly: Implications for healthcare reform. Generations 1994;18(2):55-60.
5. Families USA, Cost overdose: growth in drug spending for the elderly, 1992-2010. Washington DC, 2000.
6. Report to the President. Prescription Drug Coverage, Spending, Utilization and Prices. Washington, DC: US Department of Health and Human Services, 2000.
7. Poisal JA, Chulis GS. Medicare beneficiaries and drug coverage. Health Aff 2000;19:248-56.
8. Medigap policies and protections [cited 2002 Jan 10]. Available from: URL: www.medicare.gov/publications/pubs/pdf/finalmed.pdf.
9. Wolfe JR, Goddeeris JH. Adverse selection, moral hazard, and wealth effects in the Medigap insurance market. J Health Econ 1991;10:433-59.
10. Coulson NE, Terza JV, Neslusan CA, Stuart BC. Estimating the moral-hazard effect of supplemental medical insurance in the demand for prescription drugs in the elderly. Am Econ Rev 1995;85:122-6.
11. Coulson NE, Stuart BC. Insurance choice and the demand for prescription drugs. South Econ 1995;61:1146-57.
12. Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. Health Serv Res 1997;32(1):103-22.
13. Lassila HC, Stoehr GP, Ganguli M, Seaburg EC, Gilby JE, Belle SH, et al. Use of prescription medications in an elderly rural population: The MOVIES project. Ann Pharmacother 1996;30:589-95.
14. Dillman DA. Mail and telephone surveys: the total design method. New York: Wiley Publishing, 1978.
15. Prescription Benefits under State Medical Assistance Programs. Reston, VA: National Pharmaceutical Council, 1998.
16. Long SH. Prescription drugs and the elderly: Issues and options. Health Aff 1994;13(2):157-74.
17. Duan N, Manning WG, Morris WG, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Stats 1983;1:115-26.
18. McClellan M, Spatz ID, Carney S. Designing a Medicare prescription drug benefit: Issues, obstacles, and opportunities. Health Aff 2000;19(2): 26-41.
19. Martin BC, McMillan JA. The impact of implementing a more restrictive prescription limit on Medicaid recipients: Effects on cost therapy and out-of-pocket expenditures. Med Care 1996;34:686-701.
20. Steinberg EP, Gutierrez B, Momani A, Boscarino JA, Neuman P, Deverka P. Beyond survey data: A claims-based analysis of drug use and spending by the elderly. Health Aff 2000;19(2):198-211.
21. Osler M, Schroll M. Differences between participants and non-participants in a population study on nutrition and health in the elderly. Eur J Clin Nutr 1992;46:289-95.
22. Berk M, Schur C, Mohr P. Using survey data to estimate prescription drug costs. Health Aff 1990;9:146-57.
23. Grotzinger KM, Stuart BC, Ahern F. Assessment and control of nonresponse bias in a survey of medicine use by the elderly. Med Care 1994;32:989-1003.